EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models

Su-Yun Lyu iD, Saporie Melaku Meshesha, Chang-Eui Hong

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26010366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Su-Yun Lyu und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sunchon National University, Suncheon 57922, Republic of Korea. Hauptthemen laut MEDLINE: Cisplatin, Triple Negative Breast Neoplasms, Antineoplastic Agents, Plant Lectins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) remains a challenging subtype due to its aggressive nature and limited treatment options. This study investigated the potential synergistic effects of Korean mistletoe lectin (Viscum album L. var. coloratum agglutinin, VCA) and cisplatin on MDA-MB-231 TNBC cells using both 2D and 3D culture models. In 2D cultures, the combination of VCA and cisplatin synergistically inhibited cell proliferation, induced apoptosis, and arrested the cell cycle at the G2/M phase. Also, the combination treatment significantly reduced cell migration and invasion. Gene expression analysis showed significant changes in specific genes related to apoptosis (Bax, Bcl-2), metastasis (MMP-2, MMP-9), and EMT (E-cadherin, N-cadherin). Three-dimensional spheroid models corroborated these findings, demonstrating enhanced cytotoxicity and reduced invasion with the combination treatment. Significantly, the 3D models exhibited differential drug sensitivity compared to 2D cultures, emphasizing the importance of utilizing physiologically relevant models in preclinical studies. The combination treatment also reduced the expression of angiogenesis-related factors VEGF-A and HIF-1α. This comprehensive study provides substantial evidence for the potential of VCA and cisplatin combination therapy in TNBC treatment and underscores the significance of integrating 2D and 3D models in preclinical cancer research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinTriple Negative Breast NeoplasmsAntineoplastic AgentsPlant LectinsHumansCell Line, TumorDrug SynergismCell ProliferationApoptosisFemaleCell MovementGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

3D cell cultureKorean mistletoe lectinMDA-MB-231apoptosiscisplatinmetastasissynergistic effecttriple-negative breast cancer

Substanzen

CisplatinAntineoplastic AgentsPlant Lectins

Autor:innen und Institutionen

  • College of Pharmacy, Sunchon National University, Suncheon 57922, Republic of Korea.
  • Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea.

ORCID-Profile: Su-Yun Lyu

Zitieren

APA

Lyu, S. Y., Meshesha, S. M., & Hong, C. E. (2025). Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010366

Vancouver

Lyu SY, Meshesha SM, Hong CE. Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26010366

BibTeX
@article{Lyu2025,
  author = {Lyu, Su-Yun and Meshesha, Saporie Melaku and Hong, Chang-Eui},
  title = {Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26010366}
}
Kostenlos starten →